|Articles|March 20, 2023

Phlexglobal Announces Availability of New eTMF AI

PhlexTMF v21 will enable document submitters to improve TMF quality and speed and accuracy of submissions.

Phlexglobal has announced the general availability of PhlexTMF v21: an eTMF solution with artificial intelligence. Organizations can utilize PhlexTMF v21 to reduce TMF document misfiles and metadata errors—improving TMF quality, completeness, and timeliness.

PhlexTMF v21 immediately enables new as well as experienced document submitters to:

Improve TMF quality and reduce inspection risk
Increase the speed and accuracy of document submissions
Focus on bringing TMF best practices around quality, completeness, and timeliness into the process earlier

Reference

Phlexglobal Announces Industry-First eTMF AI that Reduces Risk of Document Misfiles and Metadata Errors to Improve TMF Quality and Inspection-Readiness. (2023, March 20). Phlexglobal.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!